Videos / Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice
In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Practical Strategies to Increase Vaccination Rates This Flu Season

MRAs for Heart Failure Update - New Developments

Abnormal LFTs – Practical Cases Expert Q&A

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

expert
Consultant Paediatric Immunologist & Paediatrician, Perth Children’s Hospital. Head, Department of Immunology, Child & Adolescent Health Service WA. Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines & Infectious Diseases, The Kids Research Institute Australia.